Recalls / Brands / Asprin And Extended-release Dipyridamole
Asprin And Extended-release Dipyridamole
1 FDA drug recall involving brand “Asprin And Extended-release Dipyridamole”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-06-29 | Class III | Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: G | Glenmark Pharmaceuticals Inc., USA |